1. Idiopathic generalized epilepsy with phantom absences, absence status, and generalized tonic-clonic seizures: A case report.
- Author
-
Jiang Y and Zhou X
- Subjects
- Female, Humans, Adult, Seizures diagnosis, Seizures drug therapy, Seizures etiology, Valproic Acid therapeutic use, Electroencephalography, Epilepsy, Generalized diagnosis, Epilepsy, Generalized drug therapy, Epilepsy, Absence diagnosis, Epilepsy, Absence drug therapy, Epilepsy, Absence complications, Status Epilepticus complications, Epilepsy, Tonic-Clonic diagnosis, Epilepsy, Tonic-Clonic drug therapy
- Abstract
Rationale: Phantom absences refer to mild and short-lasting absence seizures, which are usually accompanied by infrequent generalized tonic-clonic seizures and absence status. Generally, phantom absences do not impair the individual neurological functions. Herein, we report the case of a young woman with idiopathic generalized epilepsy, phantom absences, absence status, and generalized tonic-clonic seizures., Patient Concerns: A 31-year-old woman presented with a 16-year history of paroxysmal convulsions., Diagnoses: Electroencephalogram (EEG) showed recurrent universal and synchronized 3~4 Hz spike waves and spike-slow waves in the interictal phase with normal background activity. During the ictal phases, EEG revealed bursts of 3~4 Hz spike waves and spike-slow waves that were universal, synchronized, and symmetrical. Additionally, there was 1 seizure episode induced by a 3-Hz flash in the current case. Based on these findings, a diagnosis of idiopathic generalized epilepsy was made., Interventions: The patient was treated with oral sodium valproate, and the epileptic seizures were controlled., Outcomes: The frequency of absence seizures was significantly reduced and there were no generalized tonic-clonic seizures., Lessons: Idiopathic generalized epilepsy with phantom absences, absence status, and generalized tonic-clonic seizures is an extremely rare condition. EEG is the exclusive method for diagnosis. Antiepileptic drugs are effective for controlling epileptic seizures in this disease., Competing Interests: The authors have no funding and conflicts of interest to disclose., (Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2023
- Full Text
- View/download PDF